Wednesday, August 12, 2020
Search

Johnson - search results

If you're not happy with the results, please do another search

Hernia Mesh Lawsuits Spike, Injuries Mount – But Alternatives are Available

News about hernia mesh injuries and lawsuits have dropped off the front page in recent months – but the problem remains, as the market...

After Decades of Denial, J&J Recalls Baby Powder Because of Asbestos

The U.S. Food and Drug Administration recently discovered asbestos fibers after testing a sample of Johnson & Johnson's Baby Powder that had been purchased...

Talc Cancer Risk Spreads to Popular Cosmetics

As Johnson & Johnson continues to fight allegations that the talc in its Baby Powder contains cancer-causing asbestos, two cosmetics manufacturers have issued voluntary...

How Common Are Hernia Mesh Complications?

Despite the number of horror stories of hernia patients who have suffered debilitating pain and even died as a result of hernia mesh repairs,...

Scientists Discover the Possible Cause of Talc-Related Ovarian Cancer

A study recently published in the journal Reproductive Sciences has found the possible mechanism by which talc exposure causes ovarian cancer. A great deal...

Surgical Mesh: A Brief (and Checkered) History

Surgical mesh consists of a loosely woven sheet, made from both biological and artificial materials that have been used in a variety of corrective...

Uloric Risks and Alternatives

Since the FDA added a boxed warning to Uloric for elevated risk of fatal cardiovascular events in February 2019, physicians and patients who take...

J&J’s Baby Powder Ads Targeted Minority and Overweight Women

According to internal company documents, Johnson & Johnson marketing campaigns for Baby Powder and Shower to Shower were focused primarily on women who were...

Drug Companies Lobbying To Raise Drug Prices For Senior Citizens

Major pharmaceutical companies just can’t seem to get enough cash, and they are now lobbying the federal government to get Medicare drug discounts for...

FDA Approves New Indication for Xarelto

New Jersey-based drugmaker Johnson & Johnson (JNJ) and its partner, Bayer AG, received approval for a new indication for the controversial anti-coagulant medication Xarelto...